EurekaMag.com logo
+ Translate

Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease


, : Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. Journal of Clinical Oncology 6(6): 1047-1052

Between 1968 and 1983, 135 patients with pathologic stage (PS) I and II Hodgkin's disease were treated with extended mantle radiation technique (EMRT) at Michael Reese Hospital and the University of Chicago Center for Radiation Therapy. EMRT combines both standard mantle and para-aorta fields (M-PA) in one port. Actuarial disease-free survival at 5 and 10 years was 82.5%. Actuarial overall survival was 96% and 83% at 5 and 10 years, respectively. Acute complications were evaluated in 112 patients available for analysis. Severe nausea and vomiting occurred in 13%, weight loss of greater than 10% of body weight in 19%, and acute hematologic toxicity in 4% of patients. Bone marrow suppression was transient and did not interfere with subsequent delivery of salvage treatment with either chemotherapy or radiation therapy in 22 patients who relapsed. The cost of EMRT is 40% lower than the cost of treatment with M-PA. The median treatment time was 38 days, 33% less than the 56 days for M-PA field assuming no interruptions. These results suggest that the EMT is a safe and effective treatment tolerated by most patients. The advantages of this method are eliminating the possibility of technical error of matching between mantle and para-aortic field, decreasing overall treatment time, and reducing the cost.

(PDF same-day service: $19.90)

Accession: 005432623

PMID: 3373259

DOI: 10.1200/jco.1988.6.6.1047

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

R.F.rahl; J.U.tmann; H.G.lomb; M.G.iem; R.D.ssert; R.W.ichselbauml, 1987: Extended mantle radiation therapy for pathologic stage i and ii hodgkins disease. International Journal of Radiation Oncology*Biology*Physics 13(supp-S1): 122-0

Enrici, R.M.; Osti, M.F.; Zurlo, A.; Anselmo, A.P.; Iacari, V.; Mandelli, F., 1999: Long-term results of 60 patients with pathologic stage I & IIA Hodgkin's disease treated with exclusive mantle radiation therapy. Between January 1972 and December 1982 60 patients with pathological stage IA and IIA Hodgkin's disease (HD) were submitted to Mantle irradiation only. Twenty-five were in stage I (32.1%) and 35 in stage II (67.9%). All patients were submitte...

Enrici, R.M.urizi; Osti, M.F.lchetto; Zurlo, A.; Anselmo, A.P.ola; Iacari, V.; Mandelli, F., 1999: Long-term results of 60 patients with pathologic stage I and IIA Hodgkin's disease treated with exclusive mantle radiation therapy. Between January 1972 and December 1982 60 patients with pathological stage IA and IIA Hodgkin's disease (HD) were submitted to Mantle irradiation only. Twenty-five were in stage I (32.1%) and 35 in stage II (67.9%). All patients were submitte...

Farah, R.; Golomb, H.M.; Hallahan, D.E.; Desser, R.K.; Griem, M.L.; Blough, R.; Ultmann, J.E.; Weichselbaum, R.R., 1989: Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. Ninety-eight patients with pathological Stage (PS) III Hodgkin's disease treated between 1969 and 1984 were retrospectively analyzed. Treatment consisted of radiation therapy (RT) alone in 46 patients and combined radiation therapy and chemot...

Aref, I.; Cross, P., 2000: Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease. There is an increased incidence of breast cancer in female patients who have previously undergone mantle radiation for Hodgkin's disease. Lumpectomy followed by breast irradiation is generally considered to be contraindicated in such patients...

Frezza, G.; Barbieri, E.; Zinzani, P.L.; Babini, L.; Tura, S., 1996: Supradiaphragmatic early stage Hodgkin's disease: does mantle radiation therapy still have a role?. Extended field radiation therapy represents the main therapeutic option in early stage Hodgkin's disease with favorable prognostic features. Its role however has recently been criticized, mainly due to the high incidence of late complications...

Liao, Z.; Ha, C.S.; Vlachaki, M.T.; Hagemeister, F.; Cabanillas, F.; Hess, M.; Tucker, S.; Cox, J.D., 2001: Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure. We performed a retrospective study to determine the long-term outcome, patterns of failure, and prognostic factors for patients with pathologic Stage I or II Hodgkin's disease (HD) who were treated with mantle irradiation alone. The medical r...

Liao, Z.; Ha, C.S.; Vlachaki, M.T.; Hagemeister, F.; Cabanillas, F.; Hess, M.; Tucker, S.; Cox, J.D., 2001: Mantle irradiation alone for pathologic Stage I and II Hodgkin's disease: Long-term follow-up and patterns of failure. Purpose: We performed a retrospective study to determine the long-term outcome, patterns of failure, and prognostic factors for patients with pathologic Stage I or II Hodgkin's disease (HD) who were treated with mantle irradiation alone. Meth...

Bragg, D.G., 1989: Hodgkin disease: clinical utility of CT in initial staging and treatment, and Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphy. Investigative Radiology 24(10): 822-824

Rüffer, J.U.; Ballova, V.; Glossmann, J.; Sieber, M.; Franklin, J.; Nogova, L.; Diehl, V.; Josting, A., 2005: BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group. Patients with early stage favorable Hodgkin's disease who relapse after extended field radiotherapy have satisfactory results. We retrospectively analysed patients with relapsed HD after initial radiation therapy alone to determine treatment...